Search

Search Results for "anti-VEGF agent"

AMD/DME Case Files: Real-World Patient Profiles

Retina specialists share challenging real-world cases of wet AMD and DME.

The Art of Drug Choice: Safety in Wet AMD

AAO 2021: Protocol W and Monitoring for Wet AMD

Clinical Impacts From AAO 2020: Drs. Singh, Do, and Heier

Switching to a New Anti-VEGF Agent Early in the Course of Therapy thumbnail

Switching to a New Anti-VEGF Agent Early in the Course of Therapy

Seenu M. Hariprasad, MD

Switching Agents in DME thumbnail

Switching Agents in DME

Michael Javaheri, MD

VBS Debates: All Things Medical thumbnail

VBS Debates: All Things Medical

Dimitra Skondra, MD, PhD and Ajay Kuriyan, MD

Artificial Intelligence in Wet AMD thumbnail

Artificial Intelligence in Wet AMD

Anat Loewenstein MD

Potential Switch Case: 81-Year-Old Man With Wet AMD thumbnail

Potential Switch Case: 81-Year-Old Man With Wet AMD

Priya Sharma Vakharia, MD

Switching Agents Multiple Times in a Long-term Wet AMD Patient thumbnail

Switching Agents Multiple Times in a Long-term Wet AMD Patient

Lejla Vajzovic, MD

Real-world Switch Case: Wet AMD Patient Who Relies on Family for Transportation thumbnail

Real-world Switch Case: Wet AMD Patient Who Relies on Family for Transportation

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History thumbnail

Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague thumbnail

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switching From Aflibercept 2 mg to Faricimab in a Patient With Newly Diagnosed Neovascular AMD and Worsening Pigment Epithelium Detachment thumbnail

Switching From Aflibercept 2 mg to Faricimab in a Patient With Newly Diagnosed Neovascular AMD and Worsening Pigment Epithelium Detachment

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switch Case: Massive PED (Part 1) thumbnail

Switch Case: Massive PED (Part 1)

Yasha S. Modi, MD

Treatment Paradigms in MS: High Efficacy Early vs Escalation Approaches image

Treatment-Naïve Case: DME in a 54-Year-Old-Patient With Undiagnosed Diabetes

Joseph M. Coney, MD

Real-World Switch Case: Difficult-to-Treat Fluid DME Case Study thumbnail

Real-World Switch Case: Difficult-to-Treat Fluid DME Case Study

Ferhina Ali, MD

Thumbnail for mtkil

Kiss Case: Anti-VEGF Agents in a Case of PDR

Caroline R. Baumal, MD, Charles C. Wykoff, MD, PhD, FACS, Szilard Kiss, MD

Thumbnail for gesnit

Comparing the Efficacy of Intravitreal Anti-VEGF Agents in the Treatment of Wet AMD

Diana V. Do, MD

Meta-analysis of Anti-VEGF Agents in Wet AMD Therapy thumbnail

Meta-analysis of Anti-VEGF Agents in Wet AMD Therapy

Ramin Tadayoni, MD, PhD and Jean-Francois Korobelnik, MD, PhD

Roundtable: When and How to Approach Using Newly Approved Anti-VEGF Agents thumbnail

Roundtable: When and How to Approach Using Newly Approved Anti-VEGF Agents

Priya Sharma Vakharia, MD; Joseph M. Coney, MD; and Yasha S. Modi, MD

View More